CTEV vs GILD · rev $930.6M vs P/E 18, rev $29.44B
Claritev Corporation (CTEV) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Claritev Corporation (CTEV) is a health information services company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported CTEV revenue for 2024-12-31 was $930.6M. Net income was -$1.65B. Revenue was down 3.2% from 2023-12-31 to 2024-12-31. CTEV currently screens at market cap $440.5M.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
CTEV currently screens at market cap $440.5M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the CTEV and GILD stock pages for the full models.
Not investment advice.